Date: 2015-03-11
Type of information: Collaboration agreement
Compound: clinical trial imaging solutions
Company: Ixico (UK) VirtualScopics (USA - NY) Micron (Japan)
Therapeutic area: Technology - Services
Type agreement: collaboration
Action mechanism:
Disease:
Details: * On March 11, 2015, VirtualScopics, a provider of clinical trial imaging solutions, Ixico, a UK brain health company, and Micron, a provider of imaging services for clinical trials in Asia, jointly announced that they have entered into a collaboration agreement enhancing each company’s global clinical trial imaging solution offerings to Pharma and Biopharma companies.
Erik Jensen, vice president global business development and marketing of VirtualScopics, said “In 2014 we experienced a 25% increase in the number of awarded global Phase III trials over the previous year and we also received new study awards from 9 of the top 15 Pharma companies. We anticipate our momentum will continue in 2015. The collaboration agreement with Micron, together with our previously signed Alliance Framework Agreement with Ixico, will enable VirtualScopics to continue gaining presence with top Pharma companies and strengthen our global Phase III capabilities in the market place.”
Financial terms:
Latest news:
